Search references for IPREX. Phrases containing IPREX
See searches and references containing IPREX!IPREX
Clinical trial of an antiretroviral medication for HIV
iPrEx (from Spanish: Iniciativa Profilaxis Pre-Exposición, "pre-exposure prophylaxis initiative") was a phase III clinical trial to determine whether
IPrEx
South African nonprofit organization
participantion for the IPrEx study, which was a clinical trial testing the effects of Truvada, a pre-exposure prophylaxis for HIV infection. The IPrEx study recruited
Desmond_Tutu_HIV_Foundation
HIV prevention strategy using preventative medication for HIV-negative individuals
showed PrEP to be effective in "humanized" laboratory mice. In 2008, the iPrEx study demonstrated 42% reduction of HIV infection among men who have sex
Pre-exposure prophylaxis for HIV prevention
Pre-exposure_prophylaxis_for_HIV_prevention
American physician
AIDS editorial board of Medscape. Buchbinder was an investigator in the iPrEx study. "AAAS Members Elected as Fellows". AAAS. January 11, 2011. Retrieved
Susan_Buchbinder
American producer, actor and pornographic film director
study on PrEP, was quoted at an AIDS conference as saying that 'No one in iPrEx [the PrEP study] acquired HIV infection with a drug level that would have
Michael_Lucas_(director)
Nonprofit organization in Los Angeles
Retrieved September 1, 2023. As for driving people away from condoms, the iPrEx researchers have found that giving people Truvada has not led to riskier
AIDS_Healthcare_Foundation
American public health researcher and epidemiologist
Robert M. (2013-12-18). "No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis". PLOS ONE. 8 (12) e81997
Julia_L._Marcus
Non-profit organization
Chagas Institute. The IEC organized local volunteers to participate in the iPrEx study, which was a clinical trial testing the efficacy of a drug used as
Evandro_Chagas_Institute
Colombian LGBT activist
por las suyas". La Periódica (in Spanish). Retrieved 24 February 2024. "iPrEx-OLE, TRUVADA® et PrEp: l'expérience de la fondation équatorienne Equidad"
Orlando_Montoya
American biomedical research organization
initiative around HIV and aging. Their research has included: Leading the global iPrEx study, which led to the FDA approval of Truvada for HIV prevention in 2012
Gladstone_Institutes
LGBTQ non-profit organization in Ecuador
Fundación Ecuatoriana Equidad organized local volunteers to participate in the iPrEx study, which was a clinical trial testing the efficacy of a drug used as
Fundación_Ecuatoriana_Equidad
travel, tourism, insurance
IPREX
IPREX
IPREX
IPREX
IPREX
IPREX
IPREX
IPREX
IPREX
travel, tourism, insurance